Fingerprint
Dive into the research topics where Karen Ingrid Schreiber is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Forebyggende behandling af multipel sklerose
Filikci, Z., Schreiber, K. I. & Sørensen, P. S., 2022, In: Månedsskrift for Almen Praksis. p. 34-44 11 p., 13267.Research output: Contribution to journal › Journal article › Research › peer-review
-
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
Lefort, M., Sharmin, S., Andersen, J. B., Vukusic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., De Sèze, J., Maillart, E., Zephir, H., Labauge, P., Defer, G., Lebrun-Frenay, C., Moreau, T., Berger, E., Clavelou, P., Pelletier, J. & Stankoff, B. & 68 others, , 30 May 2022, In: BMC Medical Research Methodology. 22, 1, p. 1-14 14 p., 155.Research output: Contribution to journal › Journal article › Research › peer-review
7 Citations (Scopus) -
Symptomatisk behandling af multipel sklerose
Filikci, Z., Schreiber, K. I. & Sørensen, P. S., 2022, In: Månedsskrift for Almen Praksis. p. 706-715 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
Sharmin, S., Lefort, M., Andersen, J. B., Leray, E., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand'Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P. & Boz, C. & 31 others, , Nov 2021, In: CNS Drugs. 35, 11, p. 1217-1232 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
9 Citations (Scopus) -
The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies
Andersen, J. B., Sharmin, S., Lefort, M., Koch-Henriksen, N., Sellebjerg, F., Sørensen, P. S., Hilt Christensen, C. C., Rasmussen, P. V., Jensen, M. B., Frederiksen, J. L., Bramow, S., Mathiesen, H. K., Schreiber, K. I., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Eichau, S., Ozakbas, S. & Patti, F. & 66 others, , Aug 2021, In: Multiple Sclerosis and Related Disorders. 53, p. 103012 103012.Research output: Contribution to journal › Journal article › Research › peer-review
12 Citations (Scopus)